Imax Corp.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Imax Corp. reported revenue of $410.2M (+16.5% year on year) and net income of $45.5M (+39.2% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenue | $410.2M | $352.2M | $374.8M | $300.8M |
| Total Costs and Expenses Applicable to Revenues | $164.0M | $162.0M | $160.5M | $144.4M |
| Gross margin | $246.2M | $190.2M | $214.3M | $156.4M |
| Selling, general and administrative expenses | $138.5M | $132.7M | $144.4M | $138.0M |
| Research and development | $5.8M | $5.1M | $10.1M | $5.3M |
| Amortization of intangible assets | $7.5M | $5.8M | $4.6M | $4.8M |
| Credit loss expense (reversal), net | $696.0K | ($973.0K) | $1.8M | $8.5M |
| Asset impairments | $0 | $0 | $144.0K | $4.5M |
| Goodwill impairment | $7.0M | — | — | — |
| Restructuring charges and other impairments | $2.5M | $3.7M | $2.9M | — |
| Income from operations | $84.2M | $43.9M | $50.4M | ($4.8M) |
| Realized and unrealized investment (losses) gains | ($867.0K) | $127.0K | $465.0K | $70.0K |
| Retirement benefits non-service expense | ($243.0K) | ($387.0K) | ($411.0K) | ($556.0K) |
| Interest income | $2.8M | $2.2M | $2.5M | $1.4M |
| Interest expense | ($7.4M) | ($8.1M) | ($6.8M) | ($5.9M) |
| Induced conversion expense on settlement on convertible notes | ($15.3M) | — | — | — |
| Income before taxes | $63.3M | $37.7M | $46.1M | — |
| Income tax expense | ($17.8M) | ($5.0M) | ($13.1M) | ($10.1M) |
| Net income | $45.5M | $32.7M | $33.1M | ($19.9M) |
| Net income attributable to non-controlling interests | ($10.7M) | ($6.6M) | ($7.7M) | ($2.9M) |
| Net income attributable to common shareholders | $34.9M | $26.1M | $25.3M | ($22.8M) |
| Basic (in dollars per share) | $0.65 | $0.49 | $0.47 | -$0.40 |
| Diluted (in dollars per share) | $0.63 | $0.48 | $0.46 | -$0.40 |
| Basic (in shares) | 53.6M | 52.6M | 54.3M | 56.7M |
| Diluted (in shares) | 55.5M | 53.9M | 55.1M | 56.7M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Revenue | $102.8M | $81.4M | $106.7M | $91.7M |
| Total Costs and Expenses Applicable to Revenues | $39.9M | $35.6M | $39.4M | $38.1M |
| Gross margin | $62.9M | $45.8M | $67.3M | $53.6M |
| Selling, general and administrative expenses | $34.5M | $32.5M | $34.2M | $35.3M |
| Research and development | $1.7M | $1.8M | $1.5M | $1.5M |
| Amortization of intangible assets | $2.2M | $2.0M | $1.9M | $1.8M |
| Credit loss expense (reversal), net | $1.5M | ($460.0K) | $596.0K | ($183.0K) |
| Restructuring charges and other impairments | $2.3M | $0 | $0 | $786.0K |
| Income from operations | $20.8M | $10.0M | $29.0M | $14.3M |
| Realized and unrealized investment gains | $18.0K | $36.0K | $34.0K | $33.0K |
| Retirement benefits non-service expense | ($67.0K) | ($67.0K) | $17.0K | ($133.0K) |
| Interest income | $651.0K | $468.0K | $557.0K | $1.1M |
| Interest expense | ($2.0M) | ($1.9M) | ($1.8M) | ($1.9M) |
| Income before taxes | $19.4M | $8.5M | $27.8M | $13.4M |
| Income tax expense | ($3.5M) | ($2.4M) | ($5.2M) | ($1.2M) |
| Net income | $15.9M | $6.1M | $22.6M | $12.2M |
| Net income attributable to non-controlling interests | ($506.0K) | ($1.8M) | ($2.0M) | ($980.0K) |
| Net income attributable to common shareholders | $15.4M | $4.2M | $20.7M | $11.3M |
| Basic (in dollars per share) | $0.28 | $0.08 | $0.38 | $0.21 |
| Diluted (in dollars per share) | $0.27 | $0.07 | $0.37 | $0.20 |
| Basic (in shares) | 55.0M | 54.1M | 53.8M | 53.8M |
| Diluted (in shares) | 56.6M | 56.4M | 55.6M | 55.2M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $151.2M | $100.6M | $76.2M | $97.4M |
| Accounts receivable, net of allowance for credit losses | $108.1M | $107.7M | $136.3M | $136.1M |
| Financing receivables, net of allowance for credit losses | $122.0M | $119.9M | $127.2M | $129.4M |
| Variable consideration receivables, net of allowance for credit losses | $91.4M | $82.6M | $64.3M | $44.0M |
| Inventories | $32.5M | $32.8M | $31.6M | $31.5M |
| Prepaid expenses | $14.9M | $13.1M | $12.3M | $12.3M |
| Film assets, net of accumulated amortization | $15.5M | $8.7M | $6.8M | $5.3M |
| Property, plant and equipment, net of accumulated depreciation | $242.9M | $240.1M | $243.3M | $252.9M |
| Other assets | $24.8M | $22.4M | $20.9M | $15.7M |
| Deferred income tax assets, net of valuation allowance | $12.6M | $14.5M | $8.0M | $9.9M |
| Goodwill | $45.8M | $52.8M | $52.8M | $52.8M |
| Other intangible assets, net of accumulated amortization | $32.4M | $35.1M | $35.0M | $32.7M |
| Total assets | $894.0M | $830.4M | $814.7M | $821.2M |
| Accounts payable | $19.5M | $19.8M | $26.4M | $25.2M |
| Accrued and other liabilities | $105.3M | $100.9M | $111.0M | $117.3M |
| Deferred revenue | $50.4M | $52.7M | $67.1M | $70.9M |
| Revolving credit facility borrowings, net of unamortized debt issuance costs | $34.6M | $36.4M | $22.9M | $36.1M |
| Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs | $244.0M | $229.9M | $229.1M | $226.9M |
| Deferred income tax liabilities | $12.5M | $12.5M | $12.5M | $14.9M |
| Total liabilities | $466.3M | $452.2M | $469.1M | $491.4M |
| Non-controlling interests | $666.0K | $680.0K | $658.0K | $722.0K |
| Capital stock common shares — no par value. Authorized — Unlimited number. 53,921,676 issued and outstanding (December 31, 2024 — 52,946,200 issued and outstanding) | 419.2M | 401.4M | 389.0M | 376.7M |
| Other equity | $164.8M | $185.3M | $185.1M | $185.7M |
| Statutory surplus reserve | $4.2M | $4.1M | $3.9M | $3.9M |
| Accumulated deficit | ($240.0M) | ($274.7M) | ($292.8M) | ($293.1M) |
| Accumulated other comprehensive loss | ($10.3M) | ($16.6M) | ($12.1M) | ($9.8M) |
| Total shareholders’ equity attributable to common shareholders | $337.9M | $299.5M | $273.1M | $263.4M |
| Non-controlling interests | $89.2M | $78.1M | $71.8M | $65.7M |
| Total shareholders’ equity | $427.1M | $377.5M | $344.9M | $329.0M |
| Total liabilities and shareholders’ equity | $894.0M | $830.4M | $814.7M | $821.2M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $159.9M | $146.0M | $143.1M | $109.3M |
| Accounts receivable, net of allowance for credit losses | $114.6M | $108.5M | $108.4M | $126.9M |
| Financing receivables, net of allowance for credit losses | $118.4M | $121.3M | $118.9M | $121.1M |
| Variable consideration receivables, net of allowance for credit losses | $97.5M | $90.6M | $83.8M | $83.3M |
| Inventories | $39.2M | $35.8M | $41.4M | $36.7M |
| Prepaid expenses | $14.3M | $16.7M | $15.1M | $13.2M |
| Film assets, net of accumulated amortization | $18.4M | $16.6M | $12.0M | $10.3M |
| Property, plant and equipment, net of accumulated depreciation | $238.9M | $240.9M | $243.8M | $243.7M |
| Lease incentives and other assets | $28.6M | $27.2M | $24.0M | $23.4M |
| Deferred income tax assets, net of valuation allowance | $12.5M | $12.7M | $12.7M | $13.6M |
| Goodwill | $45.8M | $45.8M | $52.8M | $52.8M |
| Other intangible assets, net of accumulated amortization | $29.7M | $30.9M | $33.5M | $34.3M |
| Total assets | $917.9M | $893.2M | $889.6M | $868.6M |
| Accounts payable | $22.5M | $17.2M | $22.5M | $31.7M |
| Accrued and other liabilities | $96.6M | $88.1M | $96.1M | $85.3M |
| Deferred revenue | $53.2M | $56.1M | $64.5M | $55.9M |
| Revolving credit facility borrowings, net of unamortized debt issuance costs | $38.8M | $46.7M | $26.5M | $47.5M |
| Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs | $243.8M | $244.1M | $230.7M | $230.5M |
| Deferred income tax liabilities | $12.5M | $12.5M | $12.5M | $12.5M |
| Total liabilities | $467.5M | $464.8M | $452.9M | $463.5M |
| Non-controlling interests | $715.0K | $691.0K | $721.0K | $691.0K |
| Capital stock common shares — no par value. Authorized — Unlimited number. 54,842,114 issued and outstanding (December 31, 2025 — 53,921,676 issued and outstanding) | 441.3M | 429.6M | 415.6M | 415.1M |
| Other equity | $148.2M | $146.0M | $182.0M | $175.9M |
| Statutory surplus reserve | $4.2M | $4.2M | $4.2M | $4.2M |
| Accumulated deficit | ($230.8M) | ($235.7M) | ($240.6M) | ($261.3M) |
| Accumulated other comprehensive loss | ($7.1M) | ($8.7M) | ($11.7M) | ($13.6M) |
| Total shareholders’ equity attributable to common shareholders | $355.9M | $335.5M | $349.5M | $320.4M |
| Non-controlling interests | $93.8M | $92.2M | $86.5M | $84.0M |
| Total shareholders’ equity | $449.7M | $427.6M | $436.0M | $404.4M |
| Total liabilities and shareholders’ equity | $917.9M | $893.2M | $889.6M | $868.6M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $45.5M | $32.7M | $33.1M | ($19.9M) |
| Depreciation and amortization | $62.4M | $65.5M | $60.0M | $56.7M |
| Amortization of deferred financing costs | $2.0M | $2.0M | $2.2M | $3.2M |
| Credit loss expense (reversal), net | $696.0K | ($973.0K) | $1.8M | $8.5M |
| Write-downs, including goodwill and asset impairments | $9.2M | $4.0M | $1.9M | $7.2M |
| Deferred income tax expense (benefit) | $772.0K | ($5.6M) | ($1.4M) | ($2.1M) |
| Share-based and other non-cash compensation | $26.8M | $23.2M | $24.2M | $27.6M |
| Unrealized foreign currency exchange gain | ($134.0K) | ($2.8M) | ($212.0K) | $1.1M |
| Realized and unrealized investment loss (gain) | $867.0K | ($127.0K) | ($465.0K) | ($70.0K) |
| Induced conversion expense on settlement of convertible notes | $15.3M | — | — | — |
| Accounts receivable | ($1.3M) | $29.1M | ($1.9M) | ($29.0M) |
| Inventories | ($76.0K) | ($1.5M) | ($285.0K) | ($5.5M) |
| Film assets | ($25.3M) | ($25.1M) | ($20.4M) | ($19.6M) |
| Deferred revenue | ($2.4M) | ($14.3M) | ($3.9M) | ($11.6M) |
| Changes in other operating assets and liabilities | ($7.3M) | ($35.2M) | ($36.0M) | $801.0K |
| Net cash provided by operating activities | $127.1M | $70.8M | $58.6M | $17.3M |
| Purchase of property, plant and equipment | ($8.2M) | ($8.4M) | ($6.5M) | ($8.4M) |
| Investment in equipment for joint revenue sharing arrangements | ($28.4M) | ($24.3M) | ($18.0M) | ($19.8M) |
| Acquisition of other intangible assets | ($5.3M) | ($8.4M) | ($8.3M) | ($4.4M) |
| Proceeds from sale of equity securities | $0 | $0 | $1.0M | — |
| Net cash used in investing activities | ($41.9M) | ($41.2M) | ($31.8M) | ($53.3M) |
| Proceeds from issuance of convertible notes, net | $243.1M | — | — | — |
| Redemption of capped calls related to convertible notes | $30.7M | — | — | — |
| Debt issuance costs related to convertible notes | ($24.0K) | — | — | — |
| Cash paid related to repurchase of convertible notes | ($275.4M) | — | — | — |
| Purchase of capped calls related to convertible notes | ($21.9M) | — | — | — |
| Proceeds from revolving credit facility borrowings | $109.0M | $55.0M | $39.7M | $37.9M |
| Repayments of revolving credit facility borrowings | ($109.0M) | ($42.0M) | ($53.2M) | ($3.6M) |
| Proceeds from other borrowings | $0 | $0 | $322.0K | — |
| Repayment of other borrowings | ($1.1M) | ($874.0K) | ($53.0K) | — |
| Credit facility amendment fees paid | ($2.3M) | $0 | ($46.0K) | ($2.3M) |
| Repurchase of common shares | -1.5M | -18.0M | -26.8M | -83.2M |
| Taxes withheld and paid on employee stock awards vested | ($9.7M) | ($5.0M) | ($6.5M) | ($3.7M) |
| Common shares issued - stock options exercised | 4.0M | 5.3M | — | — |
| Principal payment under finance lease obligations | $0 | ($509.0K) | ($480.0K) | ($948.0K) |
| Dividends paid to non-controlling interests | $0 | $0 | ($1.4M) | ($2.7M) |
| Net cash used in financing activities | ($34.1M) | ($6.0M) | ($48.5M) | ($58.5M) |
| Effects of exchange rate changes on cash | ($497.0K) | $812.0K | $504.0K | $2.2M |
| Increase (decrease) in cash and cash equivalents during year | $50.6M | $24.4M | ($21.2M) | ($92.3M) |
| Cash and cash equivalents, beginning of year | $100.6M | $76.2M | $97.4M | $189.7M |
| Cash and cash equivalents, end of year | $151.2M | $100.6M | $76.2M | $97.4M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $22.0M | $6.1M | $43.0M | $20.4M |
| Depreciation and amortization | $30.9M | $15.2M | $46.4M | $30.8M |
| Amortization of deferred financing costs | $1.1M | $528.0K | $1.5M | $984.0K |
| Credit loss expense (reversal), net | $1.0M | ($460.0K) | $287.0K | ($309.0K) |
| Write-downs, including asset impairments | $2.3M | $57.0K | $1.3M | $1.0M |
| Deferred income tax recovery | $238.0K | ($35.0K) | $734.0K | $72.0K |
| Share-based and other non-cash compensation | $13.2M | $5.8M | $19.1M | $12.8M |
| Unrealized foreign currency exchange loss (gain) | $104.0K | $83.0K | ($170.0K) | ($278.0K) |
| Realized and unrealized investment gain | ($54.0K) | ($36.0K) | ($99.0K) | ($65.0K) |
| Accounts receivable | ($8.6M) | ($751.0K) | ($1.1M) | ($18.7M) |
| Inventories | ($6.8M) | ($3.4M) | ($8.6M) | ($4.0M) |
| Film assets | ($13.0M) | ($5.4M) | ($16.4M) | ($11.3M) |
| Lease incentives provided to exhibitor customers | ($9.9M) | ($8.7M) | — | — |
| Deferred revenue | $2.9M | $5.8M | $11.7M | $3.1M |
| Changes in other operating assets and liabilities | $698.0K | ($10.8M) | $110.0K | ($4.3M) |
| Net cash provided by operating activities | $36.0M | $4.0M | $97.7M | $30.2M |
| Purchase of property, plant and equipment | ($2.2M) | ($2.1M) | ($6.8M) | ($4.0M) |
| Investment in equipment for joint revenue sharing arrangements | ($8.7M) | ($4.0M) | ($24.1M) | ($14.7M) |
| Acquisition of other intangible assets | ($2.2M) | ($792.0K) | ($3.9M) | ($3.4M) |
| Net cash used in investing activities | ($13.0M) | ($6.9M) | ($34.8M) | ($22.0M) |
| Revolving credit facility borrowings | $38.0M | $31.0M | $85.0M | $29.0M |
| Repayments of revolving credit facility borrowings | ($34.0M) | ($19.0M) | ($93.0M) | ($18.0M) |
| Redemption of capped calls related to convertible notes | $96.0K | — | — | — |
| Settlement of convertible notes | ($743.0K) | — | — | — |
| Debt issuance costs related to convertible notes | ($946.0K) | ($944.0K) | — | — |
| Credit facility amendment fees paid | ($9.0K) | ($9.0K) | ($2.0M) | — |
| Repayments of other borrowings | ($326.0K) | ($164.0K) | ($538.0K) | ($372.0K) |
| Payments for Repurchase of Common Stock | ($13.7M) | — | ($1.5M) | ($1.5M) |
| Taxes withheld and paid on employee stock awards vested | ($17.9M) | ($17.5M) | ($9.7M) | ($9.7M) |
| Common shares issued - stock options exercised | 15.3M | 3.8M | 1.4M | 1.0M |
| Net cash (used in) provided by financing activities | ($14.3M) | ($2.8M) | ($20.4M) | $480.0K |
| Effects of exchange rate changes on cash | $38.0K | $487.0K | ($20.0K) | $46.0K |
| Increase in cash and cash equivalents during period | $8.7M | ($5.2M) | $42.5M | $8.7M |
| Cash and cash equivalents, beginning of period | $151.2M | $151.2M | $100.6M | $100.6M |
| Cash and cash equivalents, end of period | $159.9M | $146.0M | $143.1M | $109.3M |
Imax Corp. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.